Estimating immunisation coverage: is the 'third dose assumption' still valid?
نویسندگان
چکیده
Immunisation coverage is calculated from Australian Childhood Immunisation Register (ACIR) data using the 'third dose assumption'. This assumes that if the third in a series of vaccine doses has been recorded on the ACIR, the previous two doses have been received, whether or not they are recorded. The objectives of this study were to validate the 'third dose assumption', and measure the impact of the assumption on immunisation coverage estimates at 12 months of age. A sample of children born in 1999 and assessed as fully immunised at 12 months of age by applying the 'third dose assumption' were selected from the ACIR. Parents were interviewed by telephone to obtain information about vaccinations not recorded on the ACIR. Based on the survey results, the impact of the 'third-dose assumption' on national coverage estimates at 12 months of age was estimated. Of 219 surveyed children assessed as up-to-date at 12 months of age only by applying the 'third dose assumption', 212 (96.8%) met study criteria of 'definite' immunisation for all unrecorded first and second vaccine doses. Of the remaining seven, six believed all doses had been received, while one confirmed that one dose had been missed. The 'third dose assumption' overestimated coverage by 0.2 per cent, based on criteria for 'definite' immunisation. If the assumption were not used, immunisation coverage at 12 months of age in Australia would have been underestimated by 7 per cent. The 'third dose assumption' is valid and important to use in calculating immunisation coverage from the ACIR. Although ACIR reporting and coverage levels continue to improve, under-reporting of vaccine doses due at two and four months of age persists. The 'third dose assumption' may be applicable to comparable immunisation registries in other countries.
منابع مشابه
The Impact of Conflict on Immunisation Coverage in 16 Countries
Background Military conflict has been an ongoing determinant of inequitable immunisation coverage in many low- and middle-income countries, yet the impact of conflict on the attainment of global health goals has not been fully addressed. This review will describe and analyse the association between conflict, immunisation coverage and vaccine-preventable disease (VPD) outbreaks, along with...
متن کاملImpact of conflict on infant immunisation coverage in Afghanistan: a countrywide study 2000–2003
BACKGROUND Infant immunisation is an effective public health intervention to reduce the morbidity and mortality of vaccine preventable diseases. However, some developing countries fail to achieve desirable vaccination coverage; Afghanistan is one such country. The present study was performed to evaluate the progress and variation in infant immunisation coverage by district and region in Afghani...
متن کاملMissed opportunities and inappropriately given vaccines reduce immunisation coverage in facilities that serve slum areas of Nairobi.
OBJECTIVES To quantify missed opportunities for immunisation, document reasons for their occurrence and evaluate the extent of inappropriately given vaccine doses. DESIGN A cross sectional study of children under two years of age attending health facilities. SETTING Six health facilities predominantly serving the slums of Nairobi. METHODOLOGY Information on vaccination was extracted from ...
متن کاملSchool-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program.
A local general practice was contracted to provide the school-based immunisation program over two years in Mount Isa, Queensland. The schedule was for female Year 10, 11 and 12 students to receive three doses of human papilloma virus (HPV) vaccination (Gardasil). This was provided as part of the broader immunisation program that involved providing Year 8 students with two doses of hepatitis B v...
متن کاملNeed for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands
Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programmes (NIPs). In 2002, the Netherlands successfully implemented a single dose of meningococcal serogroup C conjugate vaccine at the age of 14 months a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Communicable diseases intelligence quarterly report
دوره 27 3 شماره
صفحات -
تاریخ انتشار 2003